EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases

Hisako Kayama, Kiyoshi Takeda iD

European Journal of Immunology · 2023

DOI: 10.1002/eji.202249866 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Immunology, 2023. Verfasst von Hisako Kayama und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immune Regulation, Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 229 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intestinal tract harbors diverse microorganisms, host‐ and microbiota‐derived metabolites, and potentially harmful dietary antigens. The epithelial barrier separates the mucosa, where diverse immune cells exist, from the lumen to avoid excessive immune reactions against microbes and dietary antigens. Inflammatory bowel disease (IBD), such as ulcerative colitis and Crohn's disease, is characterized by a chronic and relapsing disorder of the gastrointestinal tract. Although the precise etiology of IBD is still largely unknown, accumulating evidence suggests that IBD is multifactorial, involving host genetics and microbiota. Alterations in the metabolomic profiles and microbial community are features of IBD. Advances in mass spectrometry–based lipidomic technologies enable the identification of changes in the composition of intestinal lipid species in IBD. Because lipids have a wide range of functions, including signal transduction and cell membrane formation, the dysregulation of lipid metabolism drastically affects the physiology of the host and microorganisms. Therefore, a better understanding of the intimate interactions of intestinal lipids with host cells that are implicated in the pathogenesis of intestinal inflammation might aid in the identification of novel biomarkers and therapeutic targets for IBD. This review summarizes the current knowledge on the mechanisms by which host and microbial lipids control and maintain intestinal health and diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesCrohn DiseaseColitis, UlcerativeHumansIntestinesLipidsIntestinal Mucosa

Stichwörter der Autor:innen

Epithelial barrierG-protein-coupled receptorsInflammatory bowel diseaseMicrobiotaMucosal immunity

Substanzen

Lipids

Autor:innen und Institutionen

  • Laboratory of Immune Regulation, Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
  • WPI, Osaka University, Suita, Osaka, Japan.
  • Institute for Advanced Co-Creation Studies, Osaka University, Suita, Osaka, Japan.
  • Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Japan.
  • Center for Infection Disease Education and Research, Osaka University, Suita, Japan.

ORCID-Profile: Kiyoshi Takeda

Zitieren

APA

Kayama, H., & Takeda, K. (2023). Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases. European Journal of Immunology. https://doi.org/10.1002/eji.202249866

Vancouver

Kayama H, Takeda K. Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases. European Journal of Immunology. 2023. doi:10.1002/eji.202249866

BibTeX
@article{Kayama2023,
  author = {Kayama, Hisako and Takeda, Kiyoshi},
  title = {Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases},
  journal = {European Journal of Immunology},
  year = {2023},
  doi = {10.1002/eji.202249866}
}
Kostenlos starten →